Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab-Reference-Cited by-同舟云学术

Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab

Published:2019-04-15 Issue:7 Volume:66 Page:e27759
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Wei Ang¹^ORCID,Ma Honghao¹,Li Zhigang²,Zhang Liping¹,Zhang Rui¹^ORCID,Wang Tianyou¹

Affiliation:

1. Beijing Key Laboratory of Pediatric Hematology OncologyNational Key Discipline of Pediatrics (Capital Medical University)Key Laboratory of Major Diseases in ChildrenMinistry of Education; Hematology Oncology CenterBeijing Children's HospitalCapital Medical UniversityNational Center for Children's Health Beijing China

2. Hematology and Oncology LaboratoryBeijing Pediatric Research InstituteBeijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics Beijing China

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27759

Reference5 articles.

1. TAFRO syndrome: new subtype of idiopathic multicentric Castleman disease;Gordan S;Bosn J Basic Med Sci,2017

2. Cytokine and viral load kinetics in human herpesvirus 8‐associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis;Zondag TC;J Hematol,2016

3. The clinical spectrum of Castleman's disease

4. Improvement in Castleman's disease by humanized anti‐interleukin‐6 receptor antibody therapy;Nishimoto N;J Blood,2000

5. A phase 2, open‐label, multicenterstudy of the long‐term safety of siltuximab (an anti‐interleukin‐6 monoclonal antibody) in patients with multicentric Castleman disease;Rhee F;J Oncotarge,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reticulohistiocitosis multicéntrica con buena respuesta a tocilizumab;Medicina Clínica;2024-09

2. Pediatric Castleman Disease Combined with TAFRO Syndrome: Two Case Reports and Literature Review;2023-07-17

3. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome;The Lancet Rheumatology;2020-06